Effects of caspofungin (MK-0991) and anidulafungin (LY303366) on phagocytosis, oxidative burst and killing of Candida albicans by human phagocytes

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 9, 2004, Pages 729-731

  Frank, U ^a   Greiner, M ^a   Engels, I ^a   Daschner, F D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CONTROLLED STUDY; FLOW CYTOMETRY; INCUBATION TIME; INTRACELLULAR TRANSPORT; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; STATISTICAL SIGNIFICANCE;

ANTIBIOTICS, ANTIFUNGAL; CANDIDA ALBICANS; DRUG RESISTANCE, MULTIPLE, FUNGAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDES, CYCLIC; PHAGOCYTES; PHAGOCYTOSIS; RESPIRATORY BURST; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 4644281179     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-004-1171-z     Document Type: Article

References (12)

1. Hajdu R, Thompson R, Sundelof JG, Pelak BA, Bouffard FA, Dropinski JF, Kropp H (1997) Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991 (L-743,872). Antimicrob Agents Chemother 41:2339-2344
2. Rajman I, Desante K, Hatcher B, Hemingway J, Lachno R, Brooks S, Turik M (1997) LY30366 single intravenous dose pharmacokinetics and safety in healthy volunteers. In: Program and abstracts, 37th interscience conference on antimicrobial agents and chemotherapy. Abstract F-75
3. Chiller T, Farrokhshad K, Brummer E, Stevens DA (2001) The interaction of human monocytes, monocyte-derived macrophages, and polymorphonuclear neutrophils with caspofungin (MK-0991), an echinocandin, for antifungal activity against Aspergillus fumigatus. Diagn Microbiol Infect Dis 39:99-103
4. Chiller T, Farrokhshad K, Brummer E, Stevens DA (2000) Influence of human sera on the in vitro activity of the echinocandin caspofungin (MK-0991) against Aspergillus fumigatus. Antimicrob Agents Chemother 44:3302-3305
5. Graybill JR, Bocanegra R, Luther M, Fothergill A, Rinaldi MJ (1997) Treatment of murine Candida krusei or Candida glabrata infection with L-743,872. Antimicrob Agents Chemother 41:1937-1939
6. Graybill JR, Najvar LK, Luther MF, Fothergill AW (1997) Treatment of murine disseminated candidiasis with L-743,872. Antimicrob Agents Chemother 41:1775-1777
7. Del Poeta M, Schell WA, Perfect JR (1997) In vitro antifungal activity of pneumocandin L-743872 against a variety of clinically important molds. Antimicrob Agents Chemother 41:1835-1836
8. Denning DW (1997) Echinocandins and pneumocandins-a new antifungal class with a novel mode of action. J Antimicrob Chemother 40:611-614
9. Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Pikounis VB, Balkovec JM, Bouffard AF, Dropinski JF, Rosen H, Kropp H, Bartizal K (1997) Evaluation of the echinocandin antifungal MK-0991 (L-743, 872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother 41:2333-2338
10. Abruzzo GK, Gill CJ, Flattery AM, Kong L, Leighton C, Smith JG, Pikounis VB, Bartizal K, Rosen H (2000) Efficacy of the echinocandin caspofungin against disseminated aspergillosis and candidiasis in cyclophosphamide-induced immunosuppressed mice. Antimicrob Agents Chemother 44:2310-2318
11. Salih HR, Husfeld LM, Adam D (2000) Simultaneous cytofluorometric measurement of phagocytosis burst production and killing of human phagocytes using Candida albicans and Staphylococcus aureus as target organisms. Clin Microbiol Infect 6:251-258
12. Schneble HM, Jonas D, Engels I, Daschner FD, Frank U (1995) Effects of LY303366 on phagocytosis, oxidative burst, and intracellular killing of Candida albicans by human phagocytes. In: Program and abstracts, 39th interscience conference on antimicrobial agents and chemotherapy. Abstract no. 699